Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,497 public trials 2,844 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients

NCT06764303

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations: Hematology Hospital of the Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Active, not recruiting

Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia

NCT07187505

Conditions: Acute Promyelocytic Leukemia (APL), Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Department of Hematology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road Hefei, Anhui, China

View Trial Details

Active, not recruiting

Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors

NCT05138991

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-cells to Target CD19

NCT02935257

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: University College London Hospital London, United Kingdom

View Trial Details

Active, not recruiting

Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

NCT05192889

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, not recruiting

I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis

NCT07186478

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +14 more
Locations: RSUD Wahidin Sudirohusodo Makassar, South Sulawesi, Indonesia

View Trial Details

Active, not recruiting

Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen

NCT04219163

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, not recruiting

PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy

NCT05246670

Conditions: Chemotherapy-induced Peripheral Neuropathy, Hematologic Diseases, Hematologic Neoplasms, +5 more
Locations: Middlesex Hospital Middletown, Connecticut, United States

Carle Cancer Center NCI Community Oncology Research Program Urbana, Illinois, United States

Siouxland Regional Cancer Center Sioux City, Iowa, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Active, not recruiting

2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients

NCT02917720

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany

Universitätsmedizin Mannheim Mannheim, Baden-Wurttemberg, Germany

Klinikum rechts der Isar München, Bavaria, Germany

Medizinische Hochschule Hannover Hannover, North Rhine-Westphalia, Germany

View all 15 locations

View Trial Details

Active, not recruiting

A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma

NCT06381141

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Mayo Clinic Phoenix, Arizona, United States

Mayo Clinic Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

Mt. Sinai New York, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions